KCNA3 and Hyperkalemia: Some studies suggest that hormone replacement with fludrocortisone and the use of statin drugs can mitigate these inhibitory effects on potassium channels, offering a therapeutic effect for CNI-induced hyperkalemia (Ma, 2013; Unsal et al., 2021; Gheith et al., 2022).